Drugs Health Pharma

US regulator clears Glaukos Corp.’s drug to treat rare eye condition

The Food and Drug Administration has approved Glaukos Corporation’s drug to treat keratoconus, a rare, sight-threatening eye disease that is currently far too.

Read More